Level of Evidence for Labeled Dosing Recommendations in Renal Impairment

被引：0
|
作者：
Gagne, Joshua J.
Khan, Nazleen F.
Raj, Tara S.
Patel, Lajja R.
Choudhry, Niteesh K.
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
668
引用
收藏
页码：390 / 391
页数：2
相关论文
共 50 条
  • [41] BUPROPION DOSING RECOMMENDATIONS
    IONESCUPIOGGIA, M
    JOHNSTON, JA
    JOURNAL OF CLINICAL PSYCHIATRY, 1989, 50 (10) : 392 - 392
  • [42] BUPROPION DOSING RECOMMENDATIONS
    DAVIDSON, JRT
    JOURNAL OF CLINICAL PSYCHIATRY, 1990, 51 (02) : 83 - 83
  • [43] Recommendations for dosing antibiotics
    Abdel-Rahman, S
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (03) : 324 - 325
  • [44] DOSING RECOMMENDATIONS FOR ENCAINIDE
    ANTONACCIO, MJ
    VERJEE, S
    AMERICAN JOURNAL OF CARDIOLOGY, 1986, 58 (05): : C114 - C116
  • [45] Real-time drug dosing recommendations in patients with renal insufficiency.
    Hassan, E
    Breslow, MJ
    Rosenfeld, B
    PHARMACOTHERAPY, 2003, 23 (03): : 417 - 417
  • [46] Renal drug dosing recommendations: evaluation of product information for brands of the same drug
    Khanal, A.
    Peterson, G. M.
    Castelino, R. L.
    Jose, M. D.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (06) : 591 - 596
  • [47] Dyslipidemia in renal impairment -: From pathophysiology to evidence
    Fellström, B.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 9 - 9
  • [48] Pharmacokinetics of eplerenone after single and multiple dosing in subjects with and without renal impairment
    Ravis, WR
    Reid, S
    Sica, DA
    Tolbert, DS
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (07): : 810 - 821
  • [49] Dosing strategy for enoxaparin in patients with renal impairment presenting with acute coronary syndromes
    Green, B
    Greenwood, M
    Saltissi, D
    Westhuyzen, J
    Kluver, L
    Rowell, J
    Atherton, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (03) : 281 - 290
  • [50] Use with caution in renal impairment - implications for drug dosing in the general practice setting
    Jordan, M.
    Stewart, A.
    Blaze, J.
    Hall, J.
    Mullan, J.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2016, 12 (05): : E21 - E22
12345